UTHealth's Shervin Assassi awarded $1.4 million to personalize scleroderma treatments

(University of Texas Health Science Center at Houston) At The University of Texas Health Science Center at Houston (UTHealth), rheumatologist Shervin Assassi, M.D., is developing a blood test to determine which drugs work best for scleroderma patients with lung disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news